Anatomic Pathology Market
Number of pages: 100 | Report Format: PDF | Published date: 06 March, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market size value in 2022 |
US$ 19.09 billion |
|
Revenue forecast in 2031 |
US$ 35.53 billion |
|
Growth Rate |
CAGR of 7.3% from 2023 to 2031 |
|
Base year for estimation |
2022 |
|
Forecast Period |
2023-2031 |
|
Historical Year |
2021 |
|
Segments covered |
Product And Services, Application, End-User, and Region |
|
Regional scope |
North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
According to the deep-dive market assessment study by Growth Plus Reports, the global anatomic pathology market was valued at US$ 19.09 billion in 2022 and is expected to register a revenue CAGR of 7.3% to reach US$ 35.53 billion by 2031.
Market Fundamentals
Anatomic pathology is a branch of pathology that focuses on the study of the structure and function of organs, tissues, and cells. Anatomic pathology involves the examination of biopsy and surgical specimens to diagnose diseases and determine the extent and nature of disease in patients. Anatomic pathology can be divided into several sub-specialties, including surgical pathology which includes the examination of tissues removed during surgery to diagnose diseases, such as cancer. Cytopathology is the study of cells obtained from various body sites, such as the cervix, breast, or lungs, to diagnose diseases, such as cancer. Autopsy pathology includes the examination of organs and tissues after death to determine the cause of death and identify any underlying diseases or conditions. Neuropathology is the study of diseases of the nervous system, including the brain and spinal cord. Dermatopathology study of diseases of the skin. Anatomic pathologists use a variety of techniques and tools to examine tissues and cells, including microscopy, immunohistochemistry, molecular diagnostics, and electron microscopy. The findings are used to provide a diagnosis and guide treatment decisions for patients.
[5765767]
Market Dynamics
The increasing prevalence of cancer and other chronic diseases globally is the major factor propelling the growth of anatomic pathology market. Moreover, the rise in the adoption of advanced technologies such AI in the pathology lab equipment including gross imaging, and digital microscopes is also boosting the growth of the global market. The rise in the use of biomarkers in pathology for the diagnosis of cancers is also increasing the demand for anatomic pathology. Additionally, the growing demand for the early detection of diseases and increased focus on precision medicine is propelling the growth of the global market. Similarly, the use of digital imaging provides accurate and targeted information, and the presence of good reimbursement policy is fueling the growth in global market. The presence of robust drug pipeline for cancer is also increasing the use of anatomic pathology and continuous launch and innovation of the pathology equipment is also expected to help the expansion of the global market.
However, anatomic pathology tests and services can be expensive, particularly for advanced tests that require specialized equipment and expertise. This could limit the adoption of these tests and services, particularly in developing countries and among low-income populations. Reimbursement for anatomic pathology tests and services can also be challenging, particularly in countries with complex healthcare systems. This could limit the availability of these tests and services, particularly in the public sector. Anatomic pathology requires skilled professionals with specialized training and expertise. A shortage of such professionals could limit the availability of these tests and services, particularly in developing countries. Compliance with regulations and guidelines can be challenging for anatomic pathology laboratories, particularly in countries with complex regulatory systems. This could impact the availability and quality of these tests and services. Alternative diagnostic methods, such as liquid biopsy and imaging tests, are increasingly being used to diagnose diseases. This could limit the demand for anatomic pathology tests and services in some cases. Overall, the anatomic pathology market faces several restraints that could impact its growth and development.
Market Ecosystem
The global anatomic pathology market has been analyzed from four perspectives: Product And Services, Application, End-User, and Region
Anatomic Pathology Market by Product and Services
[85675]
Based on product and services, the global anatomic pathology market has been segmented into consumables, services, and instruments. The consumable segments held the largest market share of the global anatomic pathology market in 2022. The consumable segment is further sub-segmented into reagents & antibodies, probes & kits, and other consumables. The large share of the segment can largely be attributed to the low cost and increased demand for consumable in pathology labs. Moreover, there is great rise in the demand for reagent and kits in R&D and testing of novel drugs is also playing a significant role in the segment growth. Additionally, the major companies are continuously developing new product which is further boosting the segment growth. The increase in the demand for primary and secondary antibodies in detection, sorting or purification in pathology is also fuel the segment growth.
Anatomic Pathology Market by Application
Based on application, the global anatomic pathology market is segmented into disease diagnosis, drug discovery & development, and others. The diseases diagnosis segment dominated the global anatomic pathology market with the largest market share in 2022. The rise in the demand for early detection of the chronic diseases such as cancer is boosting the segment growth. Furthermore, anatomic pathology aids the research to study the disease cause and thus there is a rise in the application of anatomic pathology. Moreover, the growing geriatric population which is more prone to chronic diseases thus the demand for diseases diagnosis has increased. There is continuous launch and innovation of new diagnosis methods which is also propelling the segmental growth.
Anatomic Pathology Market by End User
Based on end user, the global anatomic pathology market is segmented into hospitals, research laboratories, and diagnostic laboratories. The hospitals segment held the largest share of the global anatomic pathology market in 2022. The large share of the segment can be attributed to the presence of large footfall in hospitals. Furthermore, the presence of in-house diagnosis with rise in cancer patients is propelling the segment growth. There is a presence of well-developed infrastructure with experiences professional in hospitals.
Anatomic Pathology Market by Region
Based on region, the global anatomic pathology market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global anatomic pathology market, followed by Europe in 2022. Asia Pacific is the fastest-growing regional market. The rise in the prevalence of chronic diseases and growing geriatric population is propelling the regional growth. Moreover, well developed healthcare infrastructure with rise in the healthcare expenditure in the region is boosting the regional growth. Similarly, favorable reimbursement policy and presence of major player in the region is expanding regional growth. There is rise in the demand for early diagnosis of diseases as well as government organization in the region are taking initiatives to create awareness regarding early diagnosis is fueling the regional growth.
Competitive Landscape
The prominent players operating in the global anatomic pathology market are:
Strategic Developments
The global anatomic pathology market will be valued at ~US$ 35.53 billion.
Regionally, North America held the largest market share followed by Europe; and Asia Pacific is expected to be the fastest growing region during forecast period.
Some of the prominent players operating in the global anatomic pathology market are F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Agilent Technologies, Beckton, Dickson and Compony, Laboratory Corporation of America Holdings
The diseases diagnosis segment dominates the global anatomic pathology market.
High cost, reimbursement challenges, lack of skilled professionals, and regulatory hurdles are some of the restraining factors of the market.
*Insights on financial performance are subject to the availability of information in the public domain
List of Tables
List of Figures
Using the fundamental research and knowledge services capabilities of GRG Health, Growth Plus Reports may now be tailored based on client needs.
GRG Health's unique GrowthMIX strategy and comprehensive research methodology enable us to provide unique and valuable insights to our clients while uncovering trends that would not be discovered using traditional techniques.
Snehal Deshmukh
Principle Consultant
Speak to analyst